体外研究 (In Vitro) |
DEG-77 (1-1000 nM;0.5-24 h) 在野生型 DLD1、U2OS、A549 和 TOV-21G 细胞中可诱导 CK1α、SACK1B、高磷酸化 SACK1D、SACK1F 及 SACK1G 发生剂量和时间依赖性的共同降解,但 SACK1H 不受影响,其中在 100 nM 处理 24 h 时可观察到显著的蛋白耗竭。 DEG-77 (100 nM;6 h) 介导的 CK1α、SACK1B、SACK1F 和 SACK1G 的共降解在 CRBN-/-和 CSNK1A1-/- DLD1 人结直肠癌细胞中被完全阻断,表明该过程依赖于 CRBN 和 CK1α 的表达。 DEG-77 (100 nM;6 h) 在野生型 DLD1 人结直肠癌细胞中介导的 CK1α、SACK1B、SACK1F 和 SACK1G 的共降解依赖于蛋白酶体活性,但不依赖于自噬。 DEG-77 (100 nM; 24 h) 可在稳定工程化的 HEK293T 细胞中强效且选择性地降解 IKZF2 与 CK1α,对 IKZF1 和 GSPT1 的降解作用极弱。 DEG-77 (50 nM;2 h) 可诱导 MOLM-13 急性髓系白血病细胞中 CK1α 的选择性降解,并激活 p53。 DEG-77 (100 pM-10 μM;5 d) 可在 5 天内抑制 A2780 卵巢癌细胞和 OCI-LY3 弥漫大 B 细胞淋巴瘤细胞的活力,其 EC50 为 27 和 14 nM。 DEG-77 (1 nM-10 μM;24 h) 可在 A2780 卵巢癌细胞中降解 CK1α 与 IKZF2,在 OCI-LY3 弥漫大 B 细胞淋巴瘤细胞中可降解 CK1α但对 GSPT1 无降解作用。 DEG-77 (1 μM; 24 h) 可上调 A2780 卵巢癌细胞和 OCI-LY3 弥漫性大 B 细胞淋巴瘤细胞中 Bax 和 p21 的转录水平,这表明 p53 被激活。
Western Blot Analysis
| Cell Line: |
wild-type human DLD1 colorectal cancer cells |
| Concentration: |
1, 10, 100, 500 and 1000 nM |
| Incubation Time: |
0.5-24 h |
| Result: |
Robustly depleted CK1α, SACK1F, and SACK1G protein levels, caused a substantial reduction in the 100 kDa hyperphosphorylated (CK1α-bound) form of SACK1D without affecting unphosphorylated SACK1D, and caused a modest reduction in SACK1B levels at 100 nM for 24 h. Induced a dose-dependent co-depletion of CK1α, SACK1B, hyperphosphorylated SACK1D, SACK1F, and SACK1G, with robust reduction observed at 100 nM and above across 1-1000 nM for 24 h.\n
Induced a time-dependent reduction in CK1α, SACK1B, hyperphosphorylated SACK1D, SACK1F, and SACK1G levels at 100 nM over 0.5-24 h, with CK1α reduction observed as early as 30 min, robust depletion after 1 h, peak degradation at 3 h, and depletion sustained for 24 h.\n
Left SACK1H levels unchanged across all conditions. |
Western Blot Analysis
| Cell Line: |
wild-type human U2OS osteosarcoma cells, wild-type human A549 lung adenocarcinoma cells, wild-type human TOV-21G ovarian cancer cells |
| Concentration: |
1, 10, 100, 500 and 1000 nM
|
| Incubation Time: |
0.5-24 h |
| Result: |
Induced a dose-dependent co-depletion of CK1α, hyperphosphorylated SACK1D, and SACK1G in all three cell lines, with robust reduction observed at 100 nM and above across 1-1000 nM for 24 h.\n
Reduced SACK1B levels in a dose-dependent manner in U2OS and A549 cells across 1-1000 nM for 24 h.\n
Induced a time-dependent reduction in CK1α, hyperphosphorylated SACK1D, and SACK1G levels in all three cell lines at 100 nM over 0.5-24 h, with depletion kinetics mirroring that seen in DLD1 cells.\n
Reduced SACK1B levels in a time-dependent manner in U2OS and A549 cells at 100 nM over 0.5-24 h.\n
Left SACK1H levels unchanged across all cell lines and conditions. |
Western Blot Analysis
| Cell Line: |
wild-type human DLD1 colorectal cancer cells, CRBN-/- human DLD1 colorectal cancer cells, CSNK1A1-/- (CK1α knockout) human DLD1 colorectal cancer cells |
| Concentration: |
100 nM |
| Incubation Time: |
6 h |
| Result: |
Depleted CK1α, SACK1B, SACK1F, and SACK1G levels in wild-type DLD1 cells.\n
Did not deplete CK1α, SACK1B, SACK1F, or SACK1G levels in CRBN-/- DLD1 cells.\n
Did not deplete SACK1B, SACK1F, or SACK1G levels (CK1α was not detectable) in CSNK1A1-/- DLD1 cells. |
Western Blot Analysis
| Cell Line: |
wild-type human DLD1 colorectal cancer cells |
| Concentration: |
100 nM |
| Incubation Time: |
4 h (following 2 h pre-incubation with inhibitor) |
| Result: |
Had its mediated depletion of CK1α, SACK1B, SACK1F, and SACK1G levels completely rescued by pre-treatment with 20 μM MG132.\n
Had its mediated depletion of CK1α, SACK1B, SACK1F, and SACK1G levels not rescued by pre-treatment with 50 nM bafilomycin A1. |
Western Blot Analysis
| Cell Line: |
human control skin fibroblasts (FIB03), palmoplantar keratoderma patient-derived skin fibroblasts (FIB04, homozygous SACK1G^R265P mutation with disrupted CK1α binding) |
| Concentration: |
100 nM |
| Incubation Time: |
24 h |
| Result: |
Robustly depleted CK1α and SACK1G levels, and reduced hyperphosphorylated SACK1D levels in control FIB03 fibroblasts.
Robustly depleted CK1α levels and reduced hyperphosphorylated SACK1D levels, but did not deplete SACK1G^R265P levels in patient-derived FIB04 fibroblasts. |
Western Blot Analysis
| Cell Line: |
SACK1G-/- human DLD1 colorectal cancer cells stably transduced with SACK1G-GFP, SACK1G-/- human DLD1 colorectal cancer cells stably transduced with SACK1G^R265P-GFP |
| Concentration: |
100 nM |
| Incubation Time: |
6 h |
| Result: |
Robustly depleted CK1α and SACK1F levels in all transduced cells.\n
Robustly depleted SACK1G-GFP levels in cells expressing SACK1G-GFP.\n
Did not deplete SACK1G^R265P-GFP levels in cells expressing SACK1G^R265P-GFP. |
Western Blot Analysis
| Cell Line: |
A2780 ovarian cancer cells and OCI-LY3 diffuse large B cell lymphoma cells |
| Concentration: |
1, 10, 100 nM, 1, 10 μM
|
| Incubation Time: |
24 h |
| Result: |
Induced degradation of CK1α, with relative ratio reduced to 0.17 at all concentrations ≥ 1 nM. Induced degradation of IKZF2, with relative ratio reduced to 0.06 at 10 μM. Did not induce degradation of GSPT1 at any tested concentration. |
Real Time qPCR
| Cell Line: |
A2780 ovarian cancer cells and OCI-LY3 diffuse large B cell lymphoma cells |
| Concentration: |
1 μM |
| Incubation Time: |
24 h |
| Result: |
Increased transcript levels of pro-apoptotic protein Bax. Increased transcript levels of cell cycle arrest protein p21. Left CK1α transcript levels unchanged. |
|